Earlier this week (Tuesday, January 27), France’s government survived two no-confidence votes, finally passing its contentious 2026 budget following months
Last week, France’s now five-year old medical cannabis pilot programme was extended once again, providing a bridge beyond March 2026
Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated
Augur Associates and Newsweed, two organisations at the forefront of the ongoing developments in the region, believe that the incoming system not only sidesteps many of the issues other countries have faced in the implementation phase, but that it could reestablish the country’s standing as a model of inspiration for neighbouring states and prospective forthcoming EU supra-regulation.
Reported by Newsweed.fr While the French National Agency for the Safety of Medicines (ANSM) assured at the beginning of the
2023 has been a milestone year for European cannabis. Europe’s first fully legal adult-use cannabis stores have opened in Switzerland.
We won’t spam you
